GLP-1 drugs could have a concerning effect on a user's senses of taste and smell.

This group may be taking the weight-loss drugs in contraindicated ways, researchers sugges ...

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

The video explains how Ozempic and Wegovy differ in approvals, dosing, and coverage, shaping access to diabetes and obesity ...

For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news.

Foundayo was incredibly effective at lowering A1C, which is a metric doctors use to measure average blood sugar levels over a 2 to 3-month period.

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer ...

GLP-1 RA use is associated with increased hypotensive-related events among patients with preexisting hypertension taking antihypertensive medications.

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...

For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower short-term incidence of OACs.

For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA ...